Pharmacogenomics (PGx) Community

The Pharmacogenomics Community combines the disciplines of biochemistry, biophysics, genetics, molecular biology, bioinformatics, and pharmacology to elucidate the mechanisms of drug action, toxicity, metabolism and transport and to identify genetic determinants of variability in drug exposure, response and toxicity.

Community Goals

  • Facilitate interaction and collaboration between members of the Pharmacogenomics Community via social media and networking opportunities
  • Spur interest and growth in the area of pharmacogenomics
  • Act as the primary home for researchers in the area of pharmacogenomics
  • Support member engagement in the Precision Medicine Initiative

Join the LinkedIn Group.

Programs of Interest
University of Florida Training Program
The University of Florida announces a new training program funded by the National Institutes of Health’s National Human Genomic Research Institute. The Program for Applied Research and Development in Genomic Medicine, or PARADIGM, offers trainees mentoring from world-renowned scientists, clinical exposure in multiple areas of genomic medicine and stimulating career development opportunities within the robust, interdisciplinary research environment at UF. Learn more here.

Are you interested in volunteering within the PMG Community? Email your interest to Jason Karnes, PharmD, PhD, or update your involvement interests online.
Upcoming Webinars
ASCPT Members-Only Webinar presented by the Pharmacogenomics (PGx) Community
Title:  Therapeutic Impact and Detection of Membrane Transporter Polymorphisms
Date and Time: Thursday, February 6, 2020, 12:00 pm ET
Speakers: Kathy Giacomini, PhD, Sook Wah Yee, PhD, and Alex Galetin, PhD
Moderators: Jason Sprowl, PhD
Description: In this webinar, we will provide an overview of transporter polymorphisms that are important in drug disposition and response.  We will focus on transporter polymorphisms that have a high level of evidence that they should be genotyped in drug development programs and in precision medicine.   In addition, we will describe the discovery of metabolomic biomarkers for transporters and how these biomarkers are being used in combination with modeling and simulation to predict interindividual variation in the activity of transporters due to genetic polymorphisms and drug-drug interactions. 
Registration Link: 

Past Webinars

Laura Ramsey, PhD

Community Vice Chair


Dan Hertz, Pharm, PhD

Community Vice Chair


Jason H. Karnes, PharmD, PhD, BCPS

Community Past Chair


PGx Community Programming Steering Committee
Meghan Arwood, PharmD, MS, BCPS – Chair
Brian Cicali, BS, MS
Emily Cicali, PharmD, BCPS
Naomi Gronich, MD
Yvette Martin McGrew, MD, PhD
Scott Mosley, PharmD
Gabriele Stocco, PhD
Jason Sprowl, PhD

PGx Community Membership Outreach Steering Committee

Sonal Singh, PhD – Co-Chair
D. Max Smith, PharmD, BCPS – Co-Chair
Emily J. Cicali, PharmD, BCPS
Nihal El Rouby, PharmD, PhD 
Snehal Samant, PhD
Jason A. Sprowl, PhD 

Photo Gallery
Recent News
Contact Us